Causaly announces the appointment of Saikat Das as VP Marketing

Yiannis Kiachopoulos
published on February 07, 2022

Causaly, a leader in R&D Analytics that allows researchers and specialists to intuitively map and navigate the intricate landscape of biomedical research, announced today that it has added Saikat Das to the management team as Vice President for Marketing.

By analyzing and synthesizing data from millions of scientific documents using a novel “machine reading” platform, Causaly radically increases the speed and quality of research, thereby improving R&D teams’ decision-making. Its platform is helping unleash the wave of “smart” digitalization across industry.

As Vice President of Marketing, Saikat will be responsible for building and implementing Causaly’s marketing strategy and comms, driving awareness for its products and services, and partnering with commercial teams to grow the business.

Saikat brings over 15 years of experience in blue chips, scaleups and startups across industries. In his last role, he served as Chief Marketing Officer at AMBOSS, a leading global medical knowledge platform used across 180+ countries. Prior to that, Saikat served in various marketing and commercial leadership roles across Credit Karma, Amazon and Unilever. Saikat holds an MBA from INSEAD.

Saikat said “Research has made rapid strides over the last decades resulting in ever-increasing output. As a result, researchers today are data-rich but time-poor, and have to deal with multiple data silos. Causaly’s platform helps users make sense of these collections of data - resulting in smarter, better-informed decisions. I believe this will revolutionize life sciences, and I’m incredibly excited to be a part of this journey.”

Yiannis Kiachopoulos, CEO of Causaly, said: “We are excited to announce Saikat’s appointment to the management team. 2022 is going to be a pivotal year for our business with extraordinary growth. Saikat’s wide-ranging expertise, strategic thinking, and ability to build cross-functionally will transform how we reach and educate customers about Causaly, and help unlock incredible opportunities for AI within R&D.”

Founded in 2018, Causaly’s mission is to transform how humans can find, visualize and interpret biomedical knowledge, to accelerate solutions for some of the greatest challenges we face in human health. Causaly acts as an operating system for biomedical and health data that empowers researchers to effortlessly identify new research avenues and innovative drug development opportunities. Its technology mimics human reading, and digests tens of millions of documents into an Enterprise Knowledge Graph allowing researchers and decision-makers to answer questions they can’t answer anywhere else. To learn more, visit

Watch Causaly’s panel discussion from Discovery Europe

On June 9th – 10th 2022, over 400 pharma leaders came to Berlin to take part in Discovery Europe...

  • General

Webinar - Knowledge discovery reimagined: finding new hypotheses with Causaly Cloud

It is well recognized among scientists that target selection can improve clinical trial success rates (1). Being able to stay up to date...

  • use case

How AI is redefining hypothesis generation in pharma research

It is widely recognized that the Scientific Method is fundamental for discovering new medicines. We’re all familiar with the process: a...

  • Point of View

Sign up for Causaly newsletter